Home › SEC Filings
SEC Filing Analysis
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| FCEL | 8-K | neutral | 3/10 | FuelCell Energy appointed Peter Hopper, a digital infrastructure and data center investment veteran, to its board of dir | Oct 28, 2026 |
| WB | 6-K | neutral | 2/10 | Weibo Corporation filed a 6-K announcing that its board will meet on November 17, 2026 to approve and publish its unaudi | Oct 28, 2026 |
| BTI | 6-K | neutral | 2/10 | British American Tobacco announced the appointment of Bruce Sewell, former Apple General Counsel, as an independent Non- | Oct 28, 2026 |
| KCHV | DEFA14A | neutral | 5/10 | Kochav Defense Acquisition Corp. filed additional definitive proxy soliciting materials (DEFA14A) amending the terms of | Oct 28, 2026 |
| JLL | 8-K | bullish | 6/10 | JLL reported record Q3 2026 diluted EPS of $6.85, up 49% YoY, and adjusted diluted EPS of $6.76, up 50% YoY, both above | Oct 28, 2026 |
| KCHV | 8-K | neutral | 4/10 | Kochav Defense Acquisition Corp. filed an 8-K updating the terms of its proposed extension vote. The sponsor will now co | Oct 28, 2026 |
| BLDP | PRESS-RELEASE | neutral | 3/10 | Ballard Power Systems announced the launch of the HPU Agile-H, a 80kW towable hydrogen power unit developed by its subsi | Oct 28, 2026 |
| FTV | 8-K | bullish | 6/10 | Fortive Q3 2026 revenue of $1.108B grew 7.8% YoY (core +7.2%), beating the $1.07B consensus. Adjusted EPS of $0.77 beat | Oct 28, 2026 |
| HYFM | PRESS-RELEASE | bearish | 6/10 | Hydrofarm closed a registered direct offering and concurrent private placement raising approximately $8.3 million in gro | Oct 28, 2026 |
| KCHVU | PRESS-RELEASE | neutral | 3/10 | Kochav Defense Acquisition Corp. announced that its sponsor will contribute cash to the trust account to extend the dead | Oct 28, 2026 |
| FEIM | PRESS-RELEASE | bullish | 5/10 | Frequency Electronics announced multiple U.S. Government contract awards totaling approximately $12 million for space an | Oct 28, 2026 |
| MGPI | 8-K | bearish | 5/10 | MGP Ingredients reported Q3 2026 results with sales of $117.9M (down 10% YoY) and GAAP EPS of $0.32, in line with the co | Oct 28, 2026 |
| ENVX | PRESS-RELEASE | neutral | 5/10 | Enovix declared a one-for-four warrant dividend (exercise price $3.00) to common stockholders and convertible note holde | Oct 28, 2026 |
| SIGA | PRESS-RELEASE | neutral | 3/10 | SIGA Technologies announced a new contract from the Canadian Department of National Defence for oral TPOXX (tecovirimat) | Oct 28, 2026 |
| REKR | PRESS-RELEASE | neutral | 4/10 | Rekor Systems announced a 94% increase in its FDOT contract ceiling from $4.9M to $9.5M, and a new RTC contract in Nevad | Oct 28, 2026 |
| JLL | PRESS-RELEASE | bullish | 6/10 | JLL reported Q3 2026 adjusted EPS of $6.76, beating the $6.18 consensus by 9.4%, and revenue of $7.28B, slightly above t | Oct 28, 2026 |
| SYBT | PRESS-RELEASE | bullish | 6/10 | Stock Yards Bancorp reported record Q3 2026 net income of $43.5M ($1.40 diluted), beating consensus EPS of $1.35 by 3.7% | Oct 28, 2026 |
| PVLA | PRESS-RELEASE | bullish | 7/10 | Palvella Therapeutics announced FDA acceptance and Priority Review of its NDA for QTORIN rapamycin for microcystic lymph | Oct 28, 2026 |
| MGN | 6-K | neutral | 4/10 | Megan Holdings Ltd. disclosed in a 6-K filing that two putative securities class actions were filed against it in July 2 | Oct 28, 2026 |
| PVLA | 8-K | bullish | 6/10 | Palvella Therapeutics announced that the FDA has accepted its NDA for QTORIN 3.9% rapamycin anhydrous gel for microcysti | Oct 28, 2026 |
| SYBT | 8-K | bullish | 6/10 | Stock Yards Bancorp reported record Q3 2026 net income of $43.5M ($1.40 diluted), up from $36.2M ($1.23) a year ago, dri | Oct 28, 2026 |
| EXTR | 8-K | bullish | 6/10 | Extreme Networks reported Q1 FY2027 revenue of $341.1M, up 10% YoY, and non-GAAP EPS of $0.33, up 50% YoY, with SaaS ARR | Oct 28, 2026 |
| CMRE | 6-K | bearish | 4/10 | Costamare Inc. reported Q3 2026 results with voyage revenue down 1.8% YoY to $212.1 million and net income from continui | Oct 28, 2026 |
| CMRE | PRESS-RELEASE | neutral | 5/10 | Costamare reported Q3 2026 adjusted EPS of $0.74, above the $0.66 consensus, on voyage revenue of $212.1M (vs. $209.1M c | Oct 28, 2026 |
| IP | 8-K | bullish | 6/10 | International Paper reported Q3 2026 adjusted operating EPS of $0.37, beating the $0.29 consensus, and revenue of $6.20B | Oct 28, 2026 |
| DBD | 8-K | bearish | 6/10 | Diebold Nixdorf reported Q3 2026 revenue of $994.3M (up 5.2% YoY) and adjusted EPS of $1.34, slightly above the $1.31 co | Oct 28, 2026 |
| HSBC | 6-K | neutral | 3/10 | HSBC Holdings plc announced a $1 billion share buy-back program, commencing 29 October 2026 and ending no later than 19 | Oct 28, 2026 |
| FNMA | 8-K | neutral | 5/10 | Fannie Mae reported Q3 2026 net income of $4.2 billion, up 5% from $4.0 billion in Q2 2026 and up 8% from $3.9 billion a | Oct 28, 2026 |
| ENTA | 8-K | neutral | 3/10 | Enanta Pharmaceuticals announced the planned retirement of CEO Jay R. Luly by February 1, 2027, after 23 years, and the | Oct 28, 2026 |
| RDWR | 144 | neutral | 3/10 | Two Radware officers filed Form 144 notices of intent to sell shares on the same day. Riki Goldriech (Officer) plans to | Oct 28, 2026 |